Release Date: 17/05/12 14:04 Summary: Resignation of Non-Executive Director Price Sensitive: No Download Document 91.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%